The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma

Leuk Lymphoma. 2007 Jun;48(6):1061-3. doi: 10.1080/10428190701420467.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Biomarkers, Tumor / analysis*
  • Genes, bcl-2*
  • Humans
  • Lymphoma, B-Cell / diagnosis*
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / therapy
  • Lymphoma, Large B-Cell, Diffuse / diagnosis*
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / therapy
  • Molecular Diagnostic Techniques*
  • Prognosis
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Biomarkers, Tumor
  • Rituximab